PCH
WVE icon

Polar Capital Holdings’s Wave Life Sciences WVE Stock Holding History

Polar Capital Holdings’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,062,276
Closed -$7.78M – 301
2025
Q3 		$7.78M Buy
1,062,276
+58,776
+6% +$476K 0.04% 208
2025
Q2 		$6.52M Hold
1,003,500
– – 0.03% 218
2025
Q1 		$8.11M Buy
1,003,500
+3,500
+0.4% +$38.3K 0.05% 204
2024
Q4 		$12.4M Buy
+1,000,000
New +$13.3M 0.07% 182

Other funds holding WVE

GP
GSK plc London $602M AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

Polar Capital Holdings's WVE Position: Q4 2025 in Review

Polar Capital Holdings sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 1,062,276 shares — an estimated $7.78M sold.

Polar Capital Holdings first reported a position in WVE in Q4 2024 and held it in 4 quarters. The position peaked at $12.4M in Q4 2024. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • Polar Capital Holdings reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Polar Capital Holdings sold 1,062,276 Wave Life Sciences shares in Q4 2025, an estimated $7.78M.
  • Polar Capital Holdings first reported a position in Wave Life Sciences in Q4 2024 and held it in 4 quarters.
  • Polar Capital Holdings's Wave Life Sciences position peaked at $12.4M in Q4 2024.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on Polar Capital Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.